Gene therapy for rat renal anemia with implantation of erythropoietin-transgenic myoblasts

Abstract

To investigate whether an erythropoietin (EPO) gene-based therapy could serve as an alternative to the repeated injection of rhEPO in treatment to renal anemia, the genetically modified myoblasts of rats, named Myo/ EPO, were implanted through intramuscular injection to model rats with renal anemia. The hemoglobin (Hb) and hematocrit (HCT) of the rats… (More)
DOI: 10.1007/BF02881756

Topics

2 Figures and Tables

Cite this paper

@article{Liu1999GeneTF, title={Gene therapy for rat renal anemia with implantation of erythropoietin-transgenic myoblasts}, author={Yongxue Liu and Handong Wei and Zuze Wu and Fuchu He}, journal={Science in China Series C: Life Sciences}, year={1999}, volume={42}, pages={109-112} }